A carregar...
Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
Elotuzumab is a humanized monoclonal antibody targeting the extracellular domain of signaling lymphocytic activation molecule F7 (SLAMF7) highly expressed in multiple myeloma cells. Upon binding to myeloma cells, elotuzumab exerts its cytotoxic effects through antibody-dependent cellular cytotoxicit...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5026292/ https://ncbi.nlm.nih.gov/pubmed/27695618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620716657993 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|